Purchase Order N0017316P1606
- Not listed
- The Office of Naval Research awarded a Purchase Order valued at $6,888.98 to Genscript USA Inc. on September 19, 2014, with completion targeted for December 31, 2014. This firm fixed-price contract was issued without a set-aside designation and involves protein-related products or services to be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to support the Navy's...
- <p>The Office of Naval Research issued a purchase order to Genscript USA Inc. valued at $4,444.42 on April 6, 2017, for peptide synthesis services. Work is performed in Piscataway, New Jersey, with an ultimate completion date of May 31, 2017. The order is firm fixed price with no small business set-aside.</p>
- The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
- This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....
The Office of Naval Research (ONR) awarded a $3,830.85 firm fixed price purchase order to Genscript USA Inc. on June 17, 2016, for protein services with an ultimate completion date of July 21, 2016. The contract, which was not set aside for small businesses, will be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to provide these protein-related services in support of the Navy's research initiatives. Genscript brings substantial expertise in protein production and related molecular biology services, having established itself as a critical vendor for federal research institutions across multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Agriculture. The company's capability to deliver specialized biological research materials and services makes it well-suited to support the Navy's scientific and research objectives through this relatively modest-value purchase order, which reflects a discrete procurement need within ONR's broader research portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 6/16/16 |